NCT06998407
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06998407
Title Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Avenzo Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Avenzo Therapeutics Recruiting Site RECRUITING Los Angeles California 90095 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING New Haven Connecticut 06519 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING Boston Massachusetts 02215 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING New York New York 10016 United States Details
Avenzo Therapeutics Recruiting Site NOT_YET_RECRUITING Cleveland Ohio 44106 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Nashville Tennessee 37203 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Houston Texas 77030 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING San Antonio Texas 78229 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field